Oncopiatherapeutics
Recorded under 3 name spellings.
Patents held now
No granted US patent is recorded under this name. The published applications below are what the record holds.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
6 pending
Showing 1 to 6 of 6, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page.
| Application | Title | Filed | Status |
|---|---|---|---|
| 18/821,490 | Compounds and Compositions as CBP/P300 Degraders and Uses Thereof | Aug 30, 2024 | Pending |
| 18/221,005 | Cereblon Ligands and Uses Thereof | Jul 12, 2023 | Pending |
| 18/339,429 | Methods of Identifying Compounds for Inducing Protein-Protein Interaction | Jun 22, 2023 | Pending |
| 18/850,016 | Bicyclic Heteroaryl-Containing Compounds as IKZF2 Degraders | Mar 24, 2023 | Pending |
| 18/849,796 | Cereblon Ligands and Uses Thereof | Mar 24, 2023 | Pending |
| 18/849,594 | IKZF2 Degraders and Uses Thereof | Mar 24, 2023 | Pending |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built